HEXABODY Trademark

Trademark Overview


On Monday, April 14, 2014, a trademark application was filed for HEXABODY with the United States Patent and Trademark Office. The USPTO has given the HEXABODY trademark a serial number of 79154175. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Saturday, December 3, 2022. This trademark is owned by Genmab B.V.. The HEXABODY trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

[ Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases ]

[ Chemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as fragments, monovalent antibodies, derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases ]

[ Legal services in the form of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine ]

Medical, scientific and biological research; medical, scientific and biological research in the field of antibodies, bi- and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies, bi- and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; [ computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy; ] development of pharmaceuticals containing antibodies, bi- and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these
hexabody

General Information


Serial Number79154175
Word MarkHEXABODY
Filing DateMonday, April 14, 2014
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateSaturday, December 3, 2022
Registration Number4857201
Registration DateTuesday, November 24, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 8, 2015

Trademark Statements


Goods and Services[ Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases ]
Pseudo MarkHEXA BODY
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Services[ Chemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as fragments, monovalent antibodies, derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases ]
Goods and Services[ Legal services in the form of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine ]
Goods and ServicesMedical, scientific and biological research; medical, scientific and biological research in the field of antibodies, bi- and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies, bi- and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; [ computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy; ] development of pharmaceuticals containing antibodies, bi- and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeG - NOT AVAILABLE
Class Status DateSaturday, December 3, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateSaturday, December 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 7, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status CodeG - NOT AVAILABLE
Class Status DateFriday, November 7, 2014
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenmab B.V.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNL

Party NameGenmab B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNL-3584 CM Utrecht
NL

Party NameGenmab B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNL-3584 CM Utrecht
NL

Trademark Events


Event DateEvent Description
Friday, November 7, 2014ASSIGNED TO EXAMINER
Thursday, October 30, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, October 31, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, November 7, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 11, 2014APPLICATION FILING RECEIPT MAILED
Tuesday, November 11, 2014NON-FINAL ACTION WRITTEN
Wednesday, November 12, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 13, 2014REFUSAL PROCESSED BY MPU
Thursday, November 13, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 28, 2014REFUSAL PROCESSED BY IB
Tuesday, May 12, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 12, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 12, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 12, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 12, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 3, 2015FINAL REFUSAL WRITTEN
Monday, July 20, 2015CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Wednesday, June 3, 2015FINAL REFUSAL E-MAILED
Wednesday, June 3, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 3, 2015CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, July 22, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 22, 2015EXAMINERS AMENDMENT E-MAILED
Wednesday, July 22, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 22, 2015EXAMINER'S AMENDMENT ENTERED
Wednesday, July 22, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 3, 2015ASSIGNED TO LIE
Thursday, August 6, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 19, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 19, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 19, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, September 4, 2015NOTIFICATION PROCESSED BY IB
Tuesday, September 8, 2015PUBLISHED FOR OPPOSITION
Tuesday, September 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, February 24, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, February 24, 2016FINAL DISPOSITION PROCESSED
Wednesday, February 24, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 11, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 9, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, April 20, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 10, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, June 14, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, November 24, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, November 23, 2021TEAS SECTION 71 RECEIVED
Tuesday, May 24, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 25, 2022POST REGISTRATION ACTION MAILED - SEC.71
Wednesday, November 23, 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Saturday, December 3, 2022REGISTERED - PARTIAL SEC 71 ACCEPTED
Saturday, December 3, 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, August 3, 2023PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, September 6, 2023PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, September 6, 2023INVALIDATION PROCESSED
Wednesday, June 5, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 5, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, June 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 9, 2023PARTIAL INVALIDATION PROCESSED BY THE IB